Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Michael, Shishov"'
Autor:
Julia G. Harris, Catherine A. Bingham, Sheetal S. Vora, Cagri Yildirim-Toruner, Michelle Batthish, Danielle R. Bullock, Jon M. Burnham, Danielle C. Fair, Kerry Ferraro, Suhas Ganguli, Mileka Gilbert, Beth S. Gottlieb, Olha Halyabar, Melissa M. Hazen, Ronald M. Laxer, Tzielan C. Lee, Alice Liu, Daniel J. Lovell, Melissa L. Mannion, Edward J. Oberle, Nancy Pan, Michael Shishov, Jennifer E. Weiss, Esi M. Morgan
Publikováno v:
Frontiers in Pediatrics, Vol 12 (2024)
IntroductionThe Pediatric Rheumatology Care and Outcomes Improvement Network (PR-COIN) is a North American learning health network focused on improving outcomes of children with juvenile idiopathic arthritis (JIA). JIA is a chronic autoimmune disease
Externí odkaz:
https://doaj.org/article/da5b74634a0841c1846c45d0d8ccccb8
Autor:
Kaleo Ede, Michael Shishov, Elisa Wershba, Nikita Goswami, Sabrina Gorry, Malin Joseph, Lucia Mirea, James O’Neil
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 22, Iss 1, Pp 1-5 (2024)
Abstract Background Juvenile Idiopathic Arthritis (JIA) Associated Uveitis (JIA-U) remains one of the most serious complications of JIA in children. Historically, pediatric JIA is diagnosed by an Optometrist or Ophthalmologist; however, barriers to s
Externí odkaz:
https://doaj.org/article/a32d28a96a194b04a1cb274eb2916c71
Autor:
David M. Roth, Deborah M. Levy, Michael Henrickson, Inmaculada Calvo Penades, Carlos Abud-Mendoza, Michael Shishov, Vyacheslav Chasnyk, Julia E Calderon, Antonio Nino, Diego O Viola, Alina Boteanu, Manuel A. Ferrandiz, Maria Gastanaga, Herbert Struemper, Mei-Lun Wang, Anne E. Hammer, Kenneth L. Clark, Hermine I. Brunner, Beulah Ji, Vladimir Keltsev, Nicolino Ruperto, Daniel J. Lovell, Jordi Anton, Damon Bass, Alberto Martini
Publikováno v:
Annals of the Rheumatic Diseases
ObjectivesThis ongoing Phase-2, randomised, placebo-controlled, double-blind study evaluated the efficacy, safety and pharmacokinetics of intravenous belimumab in childhood-onset systemic lupus erythematosus (cSLE).MethodsPatients (5 to 17 years) wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61b734706f2aa3a0f1bbccaacca57bd2
http://europepmc.org/articles/PMC7509523
http://europepmc.org/articles/PMC7509523
Autor:
Damon Bass, Hermine I. Brunner, Herbert Struemper, Daniel J. Lovell, Anne E. Hammer, Antonio Nino, Michael Shishov, Mei-Lun Wang, Beulah Ji, Kenneth L. Clark, Vladimir Keltsev, Julia Calderon Gallegos, Alberto Martini, Vyacheslav Chasnyk, Jordi Anton, David M. Roth, Manuel A. Ferrandiz, Alina Boteanu, Carlos Abud-Mendoza, Inmaculada Calvo, Maria Gastanaga, Deborah M. Levy, Nicolino Ruperto, Diego O Viola, Michael Henrickson
Publikováno v:
Poster Presentations.
Background: Belimumab (BEL), a monoclonal antibody targeting the B-lymphocyte stimulator, is approved in adults with active systemic lupus erythematosus (SLE). This is the first clinical trial of belimumab in pediatric patients with childhood-onset S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::854485f03a390e831712f9b03d8e401f
https://doi.org/10.1136/annrheumdis-2019-eular.4884
https://doi.org/10.1136/annrheumdis-2019-eular.4884
Autor:
Ronald M. Laxer, Jon M. Burnham, Judyann C. Olson, Sheetal S Vora, Cagri Yildirim-Toruner, Julia G. Harris, C. April Bingham, Beth Gottlieb, Mileka Gilbert, Dustin E. Fleck, Emily A. Smitherman, Michelle Batthish, Esi M. Morgan, Tzielan Lee, Michael Shishov, Jennifer E. Weiss, Bin Huang
Publikováno v:
Paediatric rheumatology.
Background Clinical remission is widely accepted as the primary target outcome for juvenile idiopathic arthritis (JIA). PR-COIN is a quality improvement collaborative that serves as a sample of pediatric rheumatology centers in North America. By meas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17060b57537c65589ea86dd5e14113ff
https://doi.org/10.1136/annrheumdis-2019-eular.4395
https://doi.org/10.1136/annrheumdis-2019-eular.4395
Autor:
Steven J. Spalding, Harry Gewanter, John F. Bohnsack, Marisa S. Klein-Gitelman, Beth Gottlieb, Timothy Beukelman, Leslie Abramson, Sampath Prahalad, Joyce J. Hsu, Jorge M. Lopez Benitez, Linda Ray, Karen Onel, Diana Milojevic, C. Egla Rabinovich, Peter R. Blier, Carol A. Wallace, Rachel E. Sobel, Elizabeth C. Chalom, Richard K. Vehe, Reema H. Syed, Audrey Hendrickson, Carol B. Lindsley, Roger Hollister, Andrew J. White, Andrea Hudgins, Michael Shishov, Kelly Rouster-Stevens, Kabita Nanda, Natasha M. Ruth, Norman T. Ilowite, Lakshmi N. Moorthy, Thomas G. Mason, Daniel J. Lovell, Sarah Ringold, Jennifer E. Weiss, Matthew L. Stoll
Publikováno v:
Arthritis Care & Research. 67:529-537
Objective Few data are available regarding the rates of serious adverse events (SAEs) and important medical events (IMEs) outside of product-based registries and clinical trials for juvenile idiopathic arthritis (JIA). The Enhanced Drug Safety Survei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6375a51ee345da6b2d50fd2b8edc0db
https://doi.org/10.1002/acr.22487
https://doi.org/10.1002/acr.22487
Autor:
Beth Gottlieb, Lawrence Jung, Claas Hinze, Daniel J. Lovell, Calvin B. Williams, Kathleen A. Haines, Thomas A. Griffin, Karen Onel, Timothy Beukelman, Tracy V. Ting, Hermine I. Brunner, Jason Dare, Anne Eberhard, Judyann C. Olson, Elaine Cassidy, Linda Wagner-Weiner, Paula W. Morris, Murray H. Passo, Daniel Kietz, Melissa S Tesher, Jay Mehta, Steven J. Spalding, Barbara Edelheit, Denise M. Costanzo, Lawrence S. Zemel, Janalee Taylor, Alexei A. Grom, Larry B. Vogler, Yukiko Kimura, Dirk Foell, Anne Johnson, Randy Q. Cron, Jennifer Huggins, James W. Verbsky, Jennifer E. Weiss, Edward H. Giannini, Suzanne C. Li, Michael Shishov, Kelly Rouster-Stevens, James J. Nocton, Bin Huang, Kenneth N. Schikler, Kaleo Ede
Publikováno v:
Arthritisrheumatology (Hoboken, N.J.). 71(3)
OBJECTIVE To determine the relationship between serum levels of S100A8/A9 and S100A12 and the maintenance of clinically inactive disease during anti-tumor necrosis factor (anti-TNF) therapy and the occurrence of disease flare following withdrawal of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2db2933fff094f64fe1d52ba4b6419d5
https://pubmed.ncbi.nlm.nih.gov/31233293
https://pubmed.ncbi.nlm.nih.gov/31233293
Autor:
Melissa S Tesher, Elaine Cassidy, Jay Mehta, Michael Shishov, Paula W. Morris, Beth Gottlieb, Kara M. Schmidt, Jason Dare, Janalee Taylor, Chen Chen, Suzanne C. Li, Anne Johnson, Steven J. Spalding, Kenneth N. Schikler, Linda Wagner-Weiner, Kaleo Ede, Edward H. Giannini, Larry B. Vogler, Kathleen A. Haines, James W. Verbsky, Thomas A. Griffin, Daniel J. Lovell, Randy Q. Cron, Dawn M. Wahezi, Judyann C. Olson, Denise M. Costanzo, Lawrence S. Zemel, Yukiko Kimura, Lawrence Jung, Murray H. Passo, Timothy Beukelman, Barbara Edelheit, B Anne Eberhard, Daniel Kietz, Kelly Rouster-Stevens, James J. Nocton, Bin Huang, Jennifer E. Weiss, Tracy V. Ting, Jennifer Huggins, Hermine I. Brunner, Alexei A. Grom, Calvin B. Williams, Karen Onel
Publikováno v:
Arthritisrheumatology (Hoboken, N.J.). 70(9)
OBJECTIVE To determine the frequency, time to flare, and predictors of disease flare upon withdrawal of anti-tumor necrosis factor (anti-TNF) therapy in children with polyarticular forms of juvenile idiopathic arthritis (JIA) who demonstrated ≥6 mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ff675add0cf32860e9a2f0ab32e8aad
https://pubmed.ncbi.nlm.nih.gov/29604189
https://pubmed.ncbi.nlm.nih.gov/29604189
Autor:
Theresa Mau, Sampath Prahalad, Anne Johnson, David M. Markovitz, Beth Gottlieb, Bin Huang, Elaine Cassidy, Daniel J. Lovell, Jay Mehta, Maureen Legendre, Karen Onel, Steven J. Spalding, Nirit Mor-Vaknin, Edward H. Giannini, Judyann C. Olson, Lawrence Jung, Smriti Mohan, Lili Zhao, Ye Yuanfan, Barbara Edelheit, Paula W. Morris, Miguel Rivas, Michael Shishov, Timothy Beukelman, Yukiko Kimura, Murray H. Passo, Barbara S. Adams
Publikováno v:
Arthritis & Rheumatology (Hoboken, N.j.)
Objective The nuclear oncoprotein DEK is an autoantigen associated with juvenile idiopathic arthritis (JIA), especially the oligoarticular subtype. DEK is a secreted chemotactic factor. Abundant levels of DEK and DEK autoantibodies are found in infla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cf84b2a29050154fc5ee5ce89ff47e7
https://pubmed.ncbi.nlm.nih.gov/29287303
https://pubmed.ncbi.nlm.nih.gov/29287303
Autor:
Gloria C. Higgins, T. Brent Graham, J. Lawrence Houk, Avis E. Ware, Hermine I. Brunner, Sri Koneru, Yolanda Farhey, Mongey Ab, Murray H. Passo, Michael Shishov
Publikováno v:
Arthritis & Rheumatism. 57:1000-1006
Objective To assess the reliability and concurrent validity of the Medication Adherence Self-report Inventory (MASRI) when used in systemic lupus erythematosus (SLE), to investigate the predictive validity of the MASRI using pharmacy refill informati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2d0db546927c0006701f9d5996bada8
https://doi.org/10.1002/art.22898
https://doi.org/10.1002/art.22898